Published in Gut on April 17, 2015
Sample storage conditions significantly influence faecal microbiome profiles. Sci Rep (2015) 1.05
Insights into the Role of Erysipelotrichaceae in the Human Host. Front Cell Infect Microbiol (2015) 0.92
Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? Front Microbiol (2016) 0.90
Potential mediators linking gut bacteria to metabolic health: a critical view. J Physiol (2016) 0.88
Talking microbes: When gut bacteria interact with diet and host organs. Mol Nutr Food Res (2015) 0.88
Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) (2016) 0.88
Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics. Front Microbiol (2016) 0.87
Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome (2017) 0.87
Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol (2016) 0.86
Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis. J Crohns Colitis (2015) 0.85
IMNGS: A comprehensive open resource of processed 16S rRNA microbial profiles for ecology and diversity studies. Sci Rep (2016) 0.83
Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol (2015) 0.80
Host and microbiota interactions are critical for development of murine Crohn's-like ileitis. Mucosal Immunol (2015) 0.80
Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med (2017) 0.79
microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Oncotarget (2016) 0.78
Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis. Front Immunol (2015) 0.77
HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases. Sci Rep (2016) 0.77
Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol (2017) 0.77
Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives. PLoS One (2016) 0.76
Paneth cell defects in Crohn's disease patients promote dysbiosis. JCI Insight (2016) 0.76
Convergence of External Crohn's Disease Risk Factors on Intestinal Bacteria. Front Immunol (2015) 0.75
Ectopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur? Front Immunol (2016) 0.75
A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow. Biomicrofluidics (2016) 0.75
Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease. Gastroenterology (2016) 0.75
Rhea: a transparent and modular R pipeline for microbial profiling based on 16S rRNA gene amplicons. PeerJ (2017) 0.75
Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model? Cell Mol Gastroenterol Hepatol (2017) 0.75
Defining dysbiosis threatens Koch's postulates and current dogma on the role of Paneth cells in Crohn's disease. Gut (2015) 0.75
Defective ATG16L1-mediated removal of IRE1α drives Crohn's disease-like ileitis. J Exp Med (2017) 0.75
Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut. Gut Microbes (2017) 0.75
LRRK2 but not ATG16L1 is associated with Paneth cell defect in Japanese Crohn's disease patients. JCI Insight (2017) 0.75
Guardians of the Gut: Enteric Defensins. Front Microbiol (2017) 0.75
Mining gut microbiome oligopeptides by functional metaproteome display. Sci Rep (2016) 0.75
Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls. Oxid Med Cell Longev (2016) 0.75
Inflammatory Bowel Disease: Influence and Implications in Reproduction. Inflamm Bowel Dis (2016) 0.75
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes (2017) 0.75
The nasal microbiota of dairy farmers is more complex than oral microbiota, reflects occupational exposure, and provides competition for staphylococci. PLoS One (2017) 0.75
In the Wnt of Paneth Cells: Immune-Epithelial Crosstalk in Small Intestinal Crohn's Disease. Front Immunol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature (2008) 10.84
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell (2008) 8.43
Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell (2007) 8.42
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43
Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity (1999) 7.34
Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10
Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2009) 6.10
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology (2004) 5.94
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature (2012) 5.63
Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05
Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest (1996) 4.59
Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe (2010) 4.54
Crohn's disease. Lancet (2012) 4.42
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology (2005) 4.10
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature (2011) 3.61
Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe (2011) 3.46
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J Biol Chem (1997) 3.42
Ulcerative colitis. Lancet (2012) 3.38
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest (2005) 3.36
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 3.28
Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol (2011) 3.21
Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut (2010) 3.10
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest (2013) 2.96
Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun (1999) 2.92
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol (2013) 2.85
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet (2010) 2.51
Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A (2011) 2.47
Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut (1998) 2.20
Paneth cells as a site of origin for intestinal inflammation. Nature (2013) 2.09
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 2.04
The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity (2012) 1.97
Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology (2011) 1.96
Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol (2013) 1.93
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis (2013) 1.79
Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature (2014) 1.78
Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med (2009) 1.71
FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim (2014) 1.64
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology (2000) 1.64
Inflammatory bowel disease as a model for translating the microbiome. Immunity (2014) 1.39
Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease. Mucosal Immunol (2008) 1.34
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol (2015) 1.33
Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe (2012) 1.28
Altered gut microbiota composition in immune-impaired Nod2(-/-) mice. Gut (2011) 1.20
Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-γ. J Exp Med (2014) 1.19
Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis. J Immunol (2007) 1.19
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol (2014) 1.17
Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. J Proteome Res (2011) 1.01
A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol (2014) 0.99
Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis. Gut Microbes (2014) 0.95
Intestinal-specific TNFα overexpression induces Crohn's-like ileitis in mice. PLoS One (2013) 0.90
Postnatal changes in the expression of genes for cryptdins 1-6 and the role of luminal bacteria in cryptdin gene expression in mouse small intestine. FEMS Immunol Med Microbiol (2008) 0.89
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features. BMC Res Notes (2014) 0.85
Antibiotics and inflammatory bowel diseases. Dig Dis (2013) 0.83
Attenuated portal hypertension in germ-free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vessels. Hepatology (2015) 0.81
Fetal exposure to maternal inflammation does not affect postnatal development of genetically-driven ileitis and colitis. PLoS One (2014) 0.79
Hungatella effluvii gen. nov., sp. nov., an obligately anaerobic bacterium isolated from an effluent treatment plant, and reclassification of Clostridium hathewayi as Hungatella hathewayi gen. nov., comb. nov. Int J Syst Evol Microbiol (2013) 0.79
Combining metagenomics with metaproteomics and stable isotope probing reveals metabolic pathways used by a naturally occurring marine methylotroph. Environ Microbiol (2015) 0.81
Age-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in Mice. PLoS Pathog (2016) 0.79
Zinc treatment is efficient against Escherichia coli α-haemolysin-induced intestinal leakage in mice. Sci Rep (2017) 0.75
Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits. J Biomater Appl (2015) 0.75
Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat diets. Sci Rep (2017) 0.75